PropertyValue
?:abstract
  • Patients with lung cancer are presumed to be at high risk from COVID-19 infection due to underlying malignancy. A total of 31 COVID-19 patients with pre-diagnosed lung cancer and 186 age and sex matched COVID-19 patients without cancer in 6 hospitals in Wuhan, China were identified in our study. There was a significantly higher level of IL-6 in lung cancer group showed by multifactorial analysis. The restricted mean survival time in 10, 20, and 53 days in COVID-19 patients with lung cancer were ealier than non-cancer COVID-19 patients in the same observation time (all P values < 0.05). Our results indicated that pre-diagnosed lung cancer was associated with higher morbidity and mortality in COVID-19 patients.
?:creator
?:doi
?:doi
  • 10.1177/1073274820960467
?:journal
  • Cancer_Control
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/b89803f2a558207f6191b81f2cf111941f55e839.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7503035.xml.json
?:pmcid
?:pmid
?:pmid
  • 32938231.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China
?:type
?:year
  • 2020-09-16

Metadata

Anon_0  
expand all